19 Nov 2026, 09:08
Periodic ReportsMS
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 19 Nov 2026, 09:08 | Invion Receives $0.5m R&D Tax Incentive Rebate | Periodic Reports | MS | 03014 | |
| 18 Nov 2026, 15:44 | Change of Director's Interest Notice - Thian Chew | Director Interests | — | 02009 | |
| 18 Nov 2026, 10:47 | Notification of cessation of securities - IVX | Securities Administration | — | 06027 | |
| 11 Nov 2026, 09:11 | IVX Director Appointment/Resignation & New Company Secretary | Company Administration | — | 12001, 12007 | |
| 29 Oct 2026, 09:03 | Appendix 4C and Quarterly Activities Report - September 2026 | Quarterly Reports | MS | 19001, 19006 | |
| 23 Oct 2026, 15:26 | Notice of Annual General Meeting/Proxy Form | Presentations | — | 08001, 08004, 14014, 16002 | |
| 21 Oct 2026, 10:51 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 21 Oct 2026, 08:52 | Funding Agreements Cover Up to 85% of Clinical Trials Costs | Capital Raising | MS | 03022, 11001 | |
| 20 Oct 2026, 08:42 | Photosoft and Novel Immunotherapy Collaboration Partnership | Company Update | — | 11001 | |
| 20 Oct 2026, 08:23 | PER: Percheron and Invion Explore Cancer Combination Therapy | Other | — | — | |
| 19 Oct 2026, 10:24 | Recruitment Conclusion for Ph 1 NMSC Trial & Advance to Ph 2 | Company Update | MS | 11001 | |
| 15 Oct 2026, 15:20 | Application for quotation of securities - IVX | Securities Administration | — | 06020 | |
| 29 Sept 2026, 16:10 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 29 Sept 2026, 16:09 | Director Loans | Capital Raising | — | 03022 | |
| 26 Aug 2026, 17:54 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 26 Aug 2026, 17:52 | Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 20 Aug 2026, 14:22 | Initial Director's Interest Notice - Paul FIeld | Director Interests | — | 02008 | |
| 20 Aug 2026, 14:21 | Final Director's Interest Notice - Alistair Bennallack | Director Interests | — | 02010 | |
| 19 Aug 2026, 09:21 | IVX Credentialed International Biotech Leader Joins Board | Company Administration | — | 12001 | |
| 31 July 2026, 13:03 | Appendix 4C and Quarterly Activities Report - June 2026 | Quarterly Reports | MS | 19004, 19009 | |
| 22 June 2026, 10:55 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 22 June 2026, 10:52 | Application for quotation of securities - IVX | Securities Administration | — | 06020 | |
| 22 June 2026, 09:24 | Global PDT Leader Dr Colin Hopper Appointed Clinical Advisor | Company Administration | — | 12008 | |
| 19 June 2026, 10:48 | Change of Directors' Interest Notices x 3 | Director Interests | — | 02009 | |
| 16 June 2026, 16:14 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 12 June 2026, 15:03 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 12 June 2026, 15:01 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 12 June 2026, 14:54 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 12 June 2026, 14:45 | Application for quotation of securities - IVX | Securities Administration | — | 06020 | |
| 29 May 2026, 17:10 | Results of Extraordinary General Meeting | Meetings & Governance | — | 08003 | |
| 19 May 2026, 09:21 | Photosoft Platform Expands to Eye Diseases Via Partnership | Company Update | MS | 11001 | |
| 11 May 2026, 16:25 | Correction to Appendix 3Y - Alistair Bennallack | Director Interests | — | 02009 | |
| 1 May 2026, 14:40 | Notification of cessation of securities - IVX | Securities Administration | — | 06027 | |
| 30 Apr 2026, 11:40 | Appendix 4C and Quarterly Activities Report - March 2026 | Quarterly Reports | MS | 19003, 19008 | |
| 28 Apr 2026, 10:54 | Notice of General Meeting/Proxy Form | Presentations | — | 08004, 08007, 14014, 16002 | |
| 22 Apr 2026, 08:51 | Bionnova 2026 Investor Presentation | Presentations | — | 03026 | |
| 21 Apr 2026, 09:46 | Skin Cancer Trial Moves to BCC With More Encouraging Signals | Company Update | MS | 11001 | |
| 20 Apr 2026, 12:19 | Appendix 3Y Clarification | Company Administration | — | 12008 | |
| 20 Apr 2026, 12:17 | Change of Director's Interest Notice - Thian Chew | Director Interests | — | 02009 | |
| 8 Apr 2026, 11:04 | Change of Substantial Holding | Substantial Holders | — | 02002 | |
| 23 Mar 2026, 11:09 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 23 Mar 2026, 11:06 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 23 Mar 2026, 11:06 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 23 Mar 2026, 11:04 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 18 Mar 2026, 16:48 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 12 Mar 2026, 11:22 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 5 Mar 2026, 12:48 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 5 Mar 2026, 12:43 | Application for quotation of securities - IVX | Securities Administration | — | 06020 | |
| 5 Mar 2026, 09:48 | Cleansing Notice - Convertible Notes | Securities Administration | — | 06009, 06018 | |
| 5 Mar 2026, 09:39 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 |